PT496 – Juan Pablo Cappello – Maintenance Doses and Recurring Revenue: The Ethics of At-Home Ketamine Therapy
Psychedelics Today
Psychedelics Today, LLC
4.6 • 598 Ratings
🗓️ 19 March 2024
⏱️ 59 minutes
🧾️ Download transcript
Summary
In this episode, Joe interviews Juan Pablo Cappello: co-founder and former CEO of Nue Life Health, whose assets were subsequently acquired by Beckley Waves.
Cappello digs into his recent article which has been making waves across the psychedelic community: "Profit Over Patients? A Critical Look at At-Home Ketamine Therapy." He created Nue Life with the goal of helping a million people address the root cause of their anxiety, and while the company was successful, he began to see a problematic trend: that using ketamine while providing services of a mental health company is very expensive and resource-consuming, and as companies saw a large percentage of clients requiring maintenance doses, the most profitable business model became essentially slinging ketamine to patients without providing any real integration or aftercare. Are these companies promising healing but really only guaranteeing recurring revenue?
He talks about:
- How this emerging model makes it harder for ethical practitioners to be able to provide their services
- The tools they built at Nue Life for long-term benefit, and why these should be the main focus – not repeated ketamine
- Matthew Perry's death and how the media was quick to place the blame on ketamine
- The need for companies and communities to come to gather and create ethical industry standards for the at-home ketamine model
- How cannabis was almost decriminalized under the Carter administration
and more!
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Hello, everybody, welcome back to psychedelics today. This is Joe Moore coming out. You're from Brackenrich, Colorado. |
| 0:19.0 | Today on the show, we have Juan Pablo Capello, former CEO and co-founder over at New Life. And we talked today about his |
| 0:28.9 | recent statements on LinkedIn about now not being able to categorically support at-home |
| 0:35.4 | ketamine and some nuance here. And it was really a great |
| 0:40.4 | conversation about, and it's time triggering for me. And for those of you listen to the show |
| 0:45.3 | regularly, you'll understand this. But yeah, like we as people interested in doctors doing |
| 0:53.1 | good medicine, medical practice. We should really look at |
| 0:56.7 | what's going on with ketamine and in question, is it good medical practice? And I don't have a |
| 1:02.1 | clear answer for you. I personally think there's ways in which we could do at home ketamine |
| 1:06.9 | well, but JP brings up some really great points here and I think we should all ponder |
| 1:12.2 | this stuff. So I hope you all enjoy this episode and share it around. And this ketamine |
| 1:19.6 | conversation really is just getting started as is the rest of the psychedelic conversation. |
| 1:24.6 | So plenty of room for us to keep developing. All right. Well, enjoy this |
| 1:29.1 | episode with Juan Pablo Capello and we will see you on the other side. |
| 1:36.6 | Hello, everybody. Welcome back to psychedelics today. We are joined today by Juan Pablo |
| 1:41.1 | Capello. How are you today? Great great great to be back on always great to |
| 1:46.0 | keep the conversation going yeah so uh you're you're a lot of things but you've been on the show |
| 1:52.2 | before um a few times i think and then i was a big fan of your your project new life when you were |
| 1:59.6 | um steering that ship it seemed like one of the |
| 2:03.1 | handful of ketamine operators I could get behind. No, I appreciate that. Yeah, you got it. And we're |
| 2:09.6 | here today to talk about at-home ketamine. You published a week or two ago an interesting piece saying, |
| 2:14.9 | I can no longer support at-home ketamine. And it made a splash. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Psychedelics Today, LLC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Psychedelics Today, LLC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.